|
Volumn 168, Issue 3, 1989, Pages 381-386
|
Novel α2-adrenoceptor antagonists show selectivity for α2A- and α2B-adrenoceptor subtypes
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE;
2 (5 CHLORO 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE;
2 (5 CHLOROISOINDOLINYLMETHYL) 2 IMIDAZOLINE;
2 ISOINDOLINYLMETHYL 2 IMIDAZOLINE DERIVATIVE;
2,3,9,13B TETRAHYDRO 1,2 DIMETHYL 1H IMIDAZO[3,4 F]MORPHANTHRIDINE;
ALPHA 2 ADRENERGIC RECEPTOR;
OXYMETAZOLINE;
PHENTOLAMINE;
PRAZOSIN;
RADIOISOTOPE;
RAUWOLSCINE;
RECEPTOR SUBTYPE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
BRAIN CORTEX;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
HUMAN;
HUMAN CELL;
LUNG;
MALE;
NONHUMAN;
NORMAL HUMAN;
PRIORITY JOURNAL;
RAT;
RECEPTOR AFFINITY;
THROMBOCYTE MEMBRANE;
VOLUNTEER;
ADRENERGIC ALPHA-ANTAGONISTS;
ANIMAL;
ANIMALS, NEWBORN;
BINDING, COMPETITIVE;
BLOOD PLATELETS;
CEREBRAL CORTEX;
IN VITRO;
KINETICS;
LUNG;
MALE;
OXYMETAZOLINE;
PRAZOSIN;
RATS;
RATS, INBRED STRAINS;
RECEPTORS, ADRENERGIC, ALPHA;
YOHIMBINE;
|
EID: 0024422263
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/0014-2999(89)90801-7 Document Type: Article |
Times cited : (110)
|
References (13)
|